Drug Profile
Q 601
Alternative Names: Q-601Latest Information Update: 31 Mar 2020
Price :
$50
*
At a glance
- Originator Qurient Co
- Class COVID-19 vaccines; Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Influenza virus infections
- Research COVID 2019 infections